Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Finasteride 1 mg effects on PSA in men with androgenetic alopecia
NCT00396175Phase 3Completed
- Sponsor
- Organon & Co.
- Start
- Mar 1998
- Primary completion
- Jan 2000
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial in androgenetic alopecia (AGA) comparing Finasteride 1 mg with Placebo (2 arms). Primary endpoint: Serum Prostate-Specific Antigen at 48 weeks. Started Mar 1998; status: completed.
02
Drugs
finasteride
03
Conditions
androgenetic alopecia (AGA)
Beyond the preview
Go deeper on NCT00396175.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00396175.